No Detail Found!

Angry Gut: Irritable Bowel Syndrome

Author(s)
Izrum Shafi Rajput Department of Pharmacology, Bahria University of Health Science, Karachi, Pakistan
Syed Ijaz Hussain Zaidi Department of Pharmacology, Bahria University of Health Science, Karachi, Pakistan
Sajid Abbas Jaffri Department of Medicine, Bahria University of Health Science, Karachi, Pakistan
Syed Wajahat Hasib Department of Anatomy, Bahria University of Health Science, Karachi, Pakistan
Kashif Razaq Department of Gastroenterology, Pakistan Navy Ship Shifa Hospital, Karachi, Pakistan
Abstract
Irritable bowel syndrome (IBS) is a functional disorder of the intestine characterized by abdominal pain and altered bowel habits. At present, no biological marker has been identified. Hence, the disease is clinically assessed on the basis of the symptoms according to ROME IV criteria. Epidemiological data revealed that the prevalence of IBS varies widely around the world, and more thorough research is needed to pinpoint any discrepancies that may exist between countries, as well as possible reasons. Both pharmacological and non-pharmacological therapy is being used in order to treat IBS. There is no specific treatment for irritable bowel disease that has come across the patients and only possible measures have been taken to treat the severity of symptoms. Symptomatic treatment with spasmolytic agent like mebeverine has been considered a standard therapy to relieve pain but to deal with constipation and diarrhea different treatment modalities have been adopted by the physician.
Publication Details
Page(s) 105-111
Published Journal: Journal of Bahria University Medical and Dental College, Volume: 12, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
diarrhea, Irritable Bowel Syndrome, constipation, ROME IV criteria
0

Citations

0

Downloads

64

Views